Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today reported on its existing technology licensees that have entered definitive contracts to use its revolutionary DehydraTECH(TM) absorption technology within their existing…
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF), a lifestyle-oriented cannabis company, on Monday announced an amendment to the share purchase agreement dated June 3, 2019 with Spring Oaks Greenhouses, Inc. Per the amended agreement, GGBXF…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, recently obtained approval from Health Canada for the licensing of all of the company’s Phase 4A buildout plans,…
California-based INmune Bio is developing therapies to battle cancers and Alzheimer’s disease by more effectively engaging the body’s own natural defenses Research published in a peer-reviewed scientific journal shows a mechanism by which scientists can…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, remains dedicated to maintaining its high standards in the midst of a growing cannabis supply gap. An article discussing the…
China’s AR industry is estimated at RMB$55 billion in 2020 Favorable Chinese government policies emphasize research and development of new technologies such as AR Few direct competitors in China create exceptional potential for AR application…
Organigram’s proprietary nano-emulsion technology is expected to provide an initial onset of effects within 10 to 15 minutes for cannabis beverages The company’s shelf-stable, thermally stable, water-compatible and palatable cannabinoid nano-emulsion formulation allows for the…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, this morning announced that it has entered into an advance payment and purchase agreement with 703454 N.B. Inc.…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the initial sale of its revolutionary BaroShear(TM)…
ETST subsidiary CTI is engaged in the research and development of cannabidiol The company has partnered with Canna Inno Laboratories Inc. to strengthen its foothold in the Canadian CBD market ETST’s Earth Science Pharma is…
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, this morning announced that its Director of Neuroscience, C.J. Barnum, and Co-Founder and CEO,…
Cannabis users have historically preferred to inhale smoke from the burned plant in order to achieve rapid-onset absorption of its properties, but Lexaria Bioscience is making it possible to achieve similar results through oral ingestion…
ETST stock recently caught the attention of InvestorPlace analyst Mark Putrino Putrino noted in an article that ETST stock stands out, because the company’s management team and advisory board exhibit impressive business experience ETST was…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced a multi-faceted expansion of its relationship with Hill Street Beverage Company Inc. (TSX.V: BEER). According to the update, the companies…
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An…
As the legal marijuana industry continues to rapidly expand, regulatory bodies in the U.S. and other parts of the world are facing lobby pressure to ensure widespread adoption Companies like Lexaria Bioscience have opposed such…
The company’s 2019 equity incentive plan is designed to help it add and retain talented employees by leveraging equity participation incentives The plan is aimed at motivating individuals who perform services for CIIX CIIX CEO…
TGOD is dedicated to high standards in the midst of a growing cannabis supply gap The company is increasing production rates and margins through its alliance with Eaton Corp. and its use of high-tech hybrid…
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that PharmHouse Inc., its 49 percent-owned joint venture, has received a cultivation license from Health Canada. According to the update, PharmHouse will immediately commence operations…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An…
INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An…
CIIX is a leading financial information provider for Chinese-speaking investors The company’s emphasis is on providing dependable market information to assist investors in making wise investment decisions CIIX is leveraging initiatives in the cryptocurrency space…
Pareteum is building on sales and acquisition successes by joining the Russell 3000 Index, granting the company a higher investment profile Pareteum’s cloud platform and related services connect millions of people in dozens of countries…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company, this morning announced entry of its wholly owned subsidiary, Khrysos Industries, into a one year supply and processing agreement to produce water soluble CBD Isolate, which…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently named Alan R. Applonie as general manager of its Modesto facility (http://ibn.fm/ndEOZ). A recent article discussing the company reads, “The appointment was made after screening of top-tier talent from…
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently reported that clinical lab tests conducted with live animals demonstrated that its new, enhanced version of DehydraTECH(TM) can deliver eight times more CBD into the blood…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was…
Research indicates that anti-inflammatory medications have the power to prevent the onset and control the symptoms of Alzheimer’s disease The link between inflammatory processes and Alzheimer’s has long been established; companies like INmune Bio are…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning released its financial results for the three and twelve months ended March 31, 2019. Audited consolidated financial statements for Canopy Rivers for the twelve months ended March…
ETST product sales rose to $770,635 for fiscal 2019, up from $463,108 in the previous year The company cited expanded distribution, increased customer awareness and rising demand for branded, high-grade, full-spectrum cannabinoid products as reasons…
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its financial results for its fiscal third quarter ended May 31, 2019. “We continued to…
TGOD is expanding into the global organic-hemp CBD market with its Global Strategic Hemp Division; the global CBD market is forecast to reach $22 billion in three years The company’s flagship Quebec facility received organic…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced its receipt of a purchase order from American Eagle Outfitters, Inc. (NYSE: AEO), through which it will sell hemp-derived cannabidiol (“CBD”) infused personal…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to…
CIIX CEO forecast that the company’s sales will reach $11-12 million by 2020 during an interview with Redchip Money Report CIIX recently opened a hemp-based CBD product retail store in the Chinese-concentrated area of San…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its entry into a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp, with Nic’s Beverages L.L.C. Under the…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced that its portfolio company, YSS Corp. (TSXV: YSS) (WKN: A2PMAX), has received five cannabis retail licenses from the Alberta Gaming, Liquor and Cannabis Commission (“AGLC”). Per…
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc, a leading licensed producer of cannabis, this morning announced a collaboration with Lift & Co. Corp. (TSXV: LIFT) (OTCQB: LFCOF) to support the…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced its entry into a securities acquisition and contribution agreement, dated as of July 8, 2019, with, among others, MXY Holdings LLC (“Moxie”). Per…